ARCHIVES

Center Leaders Ok Consortium Center Guidelines, Go Along With Most Core Grant Changes Backed By NCI

This article is from The Cancer Letter archive.

Vol. 11 No. 16 | April 19, 1985

Download PDF Visit The Full Archive

Related Articles

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

In Brief: AACR Lectures Listed; Winn Heads Community Oncology At MDA; Henderson ACS Grant Renewed

April 5, 1985

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

High Vitamin E Consumption Can Lower Liver Cancer Risks

July 27, 2012